COMMD2 had a positive correlation with mRNAsi and mDNAsi in GBM, LUAD, LIHC, BRCA, PRAD, and HNSC, but negatively correlated with mRNAsi and mDNAsi in kidney renal papillary cell carcinoma (KIRP), COAD, THCA, and PCPG. Here, COMMD2 is linked to glioblastoma.